经血管介入治疗出血性疾病的临床研究  

Clinical study on the treatment of hemorrhagic disease with blood vessel intervention

作　　者：付水平 阮玖根 胡春梅 

机构地区：[1]江西省新余市人民医院放射科,江西新余338000

出　　处：《中国当代医药》2015年第32期28-30,共3页China Modern Medicine

基　　金：江西省新余市科技计划任务(20143090834)

摘　　要：目的探讨经血管介入治疗出血性疾病的临床疗效。方法选择我院2013年6月~2015年6月收治的41例出血性疾病患者为研究对象,将其随机分为观察组21例和对照组20例,观察组给予经血管介入治疗,对照组给予内科保守治疗,比较两组止血时间、止血成功率以及不良反应发生率。结果观察组患者不良反应发生率为9.52%,平均止血时间为（1.16±0.67）d,止血成功率为100.0%;对照组患者不良反应发生率为15.00%,平均止血时间为（1.98±0.91）d,止血成功率为85.0%。两组患者各项观察指标比较,差异有统计学意义（P〈0.05）。结论经血管介入治疗出血性疾病的临床疗效确切,可减少患者手术创伤,预防出血性休克,并最大程度地保留患者相关器官功能,值得在临床上推广应用。Objective To investigate the clinical effect of interventional therapy in the treatment of hemorrhagic disease. Methods 41 patients with hemorrhagic disease were treated in our hospital from June 2013 to June 2015.The patients were randomly divided into observation group with 21 cases and control group with 20 cases.The observation group was treated by blood vessel intervention,and the control group was treated with conservative treatment.The time of hemostasis,success rate and adverse reaction rate were compared. Results The incidence of adverse reactions in the observation group was 9.52%,the average bleeding time was（1.16＋0.67） d,the success rate was 100.0%,the control group was 15.00%, the average bleeding time was（1.98＋0.91） d,the success rate was 85.0%.The two groups of patients with the observation index of the contrast were statistically different（P〈0.05）。 Conclusion The clinical efficacy of interventional therapy for hemorrhagic disease,can reduce the patients with surgical injury,prevention of hemorrhagic shock,and the greatest degree of retention of patients related organ function.It is worth to promote the use of clinical.

关 键 词：经血管介入 出血性疾病 不良反应 止血时间 

分 类 号：R619.1[医药卫生—外科学]